PharmAsia Market Study June 2000


Regular Price: USD 1,000.00

Special Price USD 700.00

30% OFF

* Required Fields

Regular Price: USD 1,000.00

Special Price USD 700.00


Be the first to review this product

Table of Contents

PharmAsia Market Study June 2000, May 2000 Market Study - Cardiovascular Diseases in JapanOverview and ScopeOverview and ScopeMarket Engineering Analysis of the Japanese Hypertension Market (1996-2006)Market DefinitionsMarket Engineering Research Measurement SystemChallenges Facing the Antihypertensive Market in JapanMarket Engineering Valuation and Revenue Forecasts (1996-2006)Market Engineering Research Analysis of HypertensionCompetitive StructureProducts in the PipelineMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsEmploy Strategic R&D to Overcome CompetitionObtain the First Choice Position by Manufacturing Superior ProductsImprove the Quality of Combination Therapy by Developing Complementary Drugs for Current First Choice AntihypertensivesExport Products to Countries Where First Choice Products and Product Lifecycle Is DifferentObtain Patents on Additional IndicationsExtend Product Line into Cardiovascular Diseases MarketDevelop Antihypertensives forPatients With Other Lifestyle-Related DiseasesSet Up the Target Groups for Antihypertensives MarketDevelop Non-Oral Antihypertensives for Alzheimer PatientsConduct Post-Marketing Clinical Surveys to Prove Efficacy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.